Accropeutics’ TYK2/JAK1 inhibitor meets endpoints in Phase II psoriasis trial
The Phase II data for AC-201 supports the progression to a Phase III trial.
Queen’s Health Sciences launches support unit for trials
Zura Bio commences Phase II trial of tibulizumab for hidradenitis suppurativa
Diversity commitment persists in clinical trials amidst policy shifts
KaliVir completes first cohort in trial for advanced solid tumours
ATS 2025: Tozorakimab’s safety reinforced with positive results from FRONTIER studies
Analysis
View More
Themes
View MoreAre regulators keeping pace with AI adoption in clinical trials?
AI is now used throughout clinical trials, from recruitment to analysis – but are regulators keeping up?
More themes
Data Insights
View MoreLeading innovators with viral vectors for the pharmaceutical industry
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms,...
Discover Data Insights powered by our proprietary data
Understand the themes driving your sector, keep up with key innovation areas and track the activities of leading companies
More Insights
Buyer's Guides
View More
GlobalData Reports
View More
1 of 2
Digital Magazine
View MorePharma Technology Focus Magazine
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
AI-automated IVF procedures represent a new era in fertility treatment
IoT can help to reduce the burden of clinical trials on patients
Mastering compliance and copyright in healthcare and MedComms
MWC Barcelona 2025: Maximizing 5G network value in the age of AI